[go: up one dir, main page]

AR115475A2 - Método para la síntesis de (1s,2r)-milnaciprán - Google Patents

Método para la síntesis de (1s,2r)-milnaciprán

Info

Publication number
AR115475A2
AR115475A2 ARP190101513A ARP190101513A AR115475A2 AR 115475 A2 AR115475 A2 AR 115475A2 AR P190101513 A ARP190101513 A AR P190101513A AR P190101513 A ARP190101513 A AR P190101513A AR 115475 A2 AR115475 A2 AR 115475A2
Authority
AR
Argentina
Prior art keywords
formula
previous step
reaction
amide
milnacipran
Prior art date
Application number
ARP190101513A
Other languages
English (en)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR115475A2 publication Critical patent/AR115475A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicación 1: Un método para sintetizar una sal de adición de ácido farmacéutica aceptable de (1S,2R)-milnaciprán de la fórmula (1), que comprende los siguientes pasos sucesivos: (a) reacción de fenilacetonitrilo y de (R)-epiclorhidrina en presencia de una base que contiene un metal alcalino, seguida por un tratamiento básico, y luego por un tratamiento ácido para obtener la lactona de la fórmula (2); (b) reacción de la lactona de fórmula (2) obtenida en el paso (a) previo con MNEt₂, en donde M representa un metal alcalino, o con NHEt₂ en presencia de un complejo de ácido de Lewis-amina en donde la amina es seleccionada entre dietilamina, trietilamina, diisopropiletilamina, N,N-dietilanilina, N,N-dimetilbencilamina, N-metilpiperidina, N-metilmorfolina, N,N’-dimetilpiperazina y hexametilentetramina, para obtener el amida-alcohol de la fórmula (3); (c) reacción del amida-alcohol de fórmula (3) obtenido en el paso (b) previo con cloruro de tionilo para obtener la amida clorada de la fórmula (4); (d) reacción de la amida clorada de fórmula (4) obtenida en el paso (c) previo con una sal de ftalimida, tal como la sal de potasio, para obtener el derivado de ftalimida de la fórmula (5); (e) hidrólisis del grupo ftalimida del derivado de ftalimida de fórmula (5) obtenido en el paso (d) previo, para obtener (1S,2R)-milnaciprán; y (f) salificación del (1S,2R)-milnaciprán obtenido en el paso (e) previo en un sistema adecuado de solventes, en presencia de un ácido farmacéuticamente aceptable, caracterizado porque los pasos (a) a (e) son llevados a cabo en un medio de reacción que comprende un mismo y único solvente que es tolueno.
ARP190101513A 2009-01-29 2019-06-04 Método para la síntesis de (1s,2r)-milnaciprán AR115475A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0950552A FR2941454B1 (fr) 2009-01-29 2009-01-29 Proced de synthese du (1s,2r)-milnacipran

Publications (1)

Publication Number Publication Date
AR115475A2 true AR115475A2 (es) 2021-01-20

Family

ID=40920574

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP100100245A AR077526A1 (es) 2009-01-29 2010-01-29 Metodo para la sintesis de (1s,2r)- milnacipran
ARP190101513A AR115475A2 (es) 2009-01-29 2019-06-04 Método para la síntesis de (1s,2r)-milnaciprán

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP100100245A AR077526A1 (es) 2009-01-29 2010-01-29 Metodo para la sintesis de (1s,2r)- milnacipran

Country Status (23)

Country Link
US (1) US8604241B2 (es)
EP (1) EP2391599B1 (es)
JP (1) JP5646509B2 (es)
KR (1) KR101719011B1 (es)
CN (2) CN110204455A (es)
AR (2) AR077526A1 (es)
AU (1) AU2010209686B2 (es)
BR (1) BRPI1007404B8 (es)
CA (1) CA2750488C (es)
ES (1) ES2472695T3 (es)
FR (1) FR2941454B1 (es)
GE (1) GEP20135903B (es)
IL (1) IL214241A (es)
MA (1) MA33025B1 (es)
MX (1) MX2011007846A (es)
NZ (1) NZ594291A (es)
PL (1) PL2391599T3 (es)
RU (1) RU2521342C2 (es)
TN (1) TN2011000363A1 (es)
TW (1) TWI455911B (es)
UA (1) UA104884C2 (es)
WO (1) WO2010086394A1 (es)
ZA (1) ZA201105414B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944011B1 (fr) * 2009-04-03 2011-05-20 Pf Medicament Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments.
WO2011158249A1 (en) * 2010-06-16 2011-12-22 Glenmark Generics Limited Process for preparation of milnacipran intermediate and its use in preparation of pure milnacipran
WO2012046247A2 (en) * 2010-10-06 2012-04-12 Msn Laboratories Limited Process for the preparation of (±m1r(s), 2srr)l-2-(aminomethyl)-n,n-diethyl-l-phenylcyclopropane carboxamide hydrochloride
MX2013008595A (es) * 2011-01-24 2013-08-14 Bayer Ip Gmbh Procedimiento mejorado para la preparacion de 2,2-difluoroetilamina.
ES2733750T3 (es) * 2012-02-17 2019-12-02 Eisai R&D Man Co Ltd Métodos y compuestos útiles en la síntesis de antagonistas del receptor de orexina-2
WO2014009767A1 (en) 2012-07-07 2014-01-16 Micro Labs Limited An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts
EP2805936A1 (en) 2013-05-20 2014-11-26 Cosma S.p.A. Process for preparing levomilnacipran HCL
WO2014203277A2 (en) * 2013-06-19 2014-12-24 Msn Laboratories Private Limited Process for the preparation of (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanearboxamide hydrochloride
CN103694162B (zh) * 2014-01-03 2015-09-02 上海现代制药股份有限公司 (1s,2r)-1-苯基2-(酞酰亚胺)甲基-n,n-二乙基-环丙甲酰胺的制备方法
CN104058992A (zh) * 2014-06-13 2014-09-24 上海现代制药股份有限公司 左旋米那普仑盐酸盐的晶型
WO2016050894A1 (en) 2014-10-03 2016-04-07 Purac Biochem Bv Method for the manufacture of n, n-diallkyllactamide
US10131624B2 (en) 2014-11-04 2018-11-20 Quimica Sintetica, S.A. Process for the preparation of (1S,2R)-Milnacipran
CN106083638A (zh) * 2016-07-07 2016-11-09 佛山市隆信医药科技有限公司 一种盐酸左旋米那普仑的制备方法
CN111175387B (zh) * 2018-11-13 2022-06-07 成都康弘药业集团股份有限公司 一种米那普仑异构体的检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508035A1 (fr) 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2581059B1 (fr) 1985-04-25 1988-04-22 Pf Medicament Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z)
FR2640972B1 (es) 1988-12-28 1991-04-19 Pf Medicament
JPH0834765A (ja) * 1994-02-22 1996-02-06 Asahi Chem Ind Co Ltd アミノアルキルシクロプロパン誘導体
EP0747348A4 (en) 1994-02-22 1999-07-07 Asahi Chemical Ind AMINOALKYLCYCLOPROPAN DERIVATIVES
US7309799B2 (en) 2004-06-01 2007-12-18 Collegium Pharmaceutical, Inc. Methods for the synthesis of milnacipran and congeners thereof
JP4712320B2 (ja) * 2004-06-16 2011-06-29 住友化学株式会社 2−オキソ−1−フェニル−3−オキサビシクロ[3.1.0]ヘキサンの製造方法
JP4418717B2 (ja) * 2004-06-24 2010-02-24 住友化学株式会社 (z)−1−フェニル−1−ジエチルアミノカルボニル−2−アミノメチルシクロプロパン塩酸塩の製造方法
KR101070721B1 (ko) 2004-06-25 2011-10-07 스미또모 가가꾸 가부시키가이샤 (z)-1-페닐-1-디에틸아미노카르보닐-2-히드록시메틸시클로프로판의 제조 방법
JP4828863B2 (ja) 2005-01-28 2011-11-30 住友化学株式会社 (z)−1−フェニル−1−(n,n−ジエチルアミノカルボニル)−2−フタルイミドメチルシクロプロパンの製造方法
KR100772244B1 (ko) * 2005-07-20 2007-11-01 안국약품 주식회사 밀나시프란염산염의 제조방법
CN102986288B (zh) 2009-12-04 2016-12-07 交互数字专利控股公司 用于混合网络中的汇聚网关的扩展本地ip接入

Also Published As

Publication number Publication date
BRPI1007404B1 (pt) 2020-10-13
IL214241A0 (en) 2011-09-27
NZ594291A (en) 2012-11-30
AU2010209686A1 (en) 2011-08-18
GEP20135903B (en) 2013-08-12
US8604241B2 (en) 2013-12-10
AR077526A1 (es) 2011-09-07
KR20110108409A (ko) 2011-10-05
JP5646509B2 (ja) 2014-12-24
CA2750488A1 (en) 2010-08-05
IL214241A (en) 2015-03-31
EP2391599B1 (en) 2014-04-09
CN102300840A (zh) 2011-12-28
US20110295036A1 (en) 2011-12-01
JP2012516307A (ja) 2012-07-19
TN2011000363A1 (en) 2013-03-27
EP2391599A1 (en) 2011-12-07
UA104884C2 (uk) 2014-03-25
MA33025B1 (fr) 2012-02-01
TW201031623A (en) 2010-09-01
RU2521342C2 (ru) 2014-06-27
FR2941454A1 (fr) 2010-07-30
WO2010086394A1 (en) 2010-08-05
FR2941454B1 (fr) 2011-04-01
ES2472695T3 (es) 2014-07-02
BRPI1007404A2 (pt) 2016-02-16
MX2011007846A (es) 2011-12-14
TWI455911B (zh) 2014-10-11
ZA201105414B (en) 2012-03-28
AU2010209686B2 (en) 2014-06-05
RU2011135326A (ru) 2013-03-10
CN110204455A (zh) 2019-09-06
PL2391599T3 (pl) 2014-09-30
BRPI1007404B8 (pt) 2021-05-25
CA2750488C (en) 2016-12-13
KR101719011B1 (ko) 2017-03-22

Similar Documents

Publication Publication Date Title
AR115475A2 (es) Método para la síntesis de (1s,2r)-milnaciprán
JP5186722B2 (ja) スルフリルフルオリドを用いるフッ素化反応
RU2015142826A (ru) Способ получения натриевой соли (2s, 5r)-2-карбоксамидо-7-оксо-6-сульфоокси-1, 6-диаза-бицикло[3.2.1]октана
EA201290872A1 (ru) Способ получения бензоксаборолов
RU2018132264A (ru) Промежуточные продукты в синтезе эрибулина и соответствующие способы синтеза
CO6290754A2 (es) Método para producir bicarbonato de arginina
PE20090956A1 (es) PROCESO PARA LA OBTENCION DE DERIVADOS DE PIRIDO [2,1-a] - ISOQUINOLINA
Neelarapu et al. A one-pot selective synthesis of N-Boc protected secondary amines: tandem direct reductive amination/N-Boc protection
JP5681985B2 (ja) 二酸化炭素固定化による尿素化合物の製造法
CN1331849C (zh) 甲砜霉素和氟苯尼考的新合成方法及其关键中间体
NO20082271L (no) Framgangsmate for framstilling av ioheksol
CN103709194B (zh) 光学活性的羟基保护的脂肪族磷酸酯的制备方法
JP6377676B2 (ja) 新規なヒドロキサム酸誘導体の製造方法
AR047686A1 (es) Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable
Mao et al. A practical, chemoselective approach to O-methylation of carboxylic acids with dimethyl malonate
US11708341B2 (en) Synthesis of (S)-2-amino-4-methyl-((R)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
Lee et al. Ring-opening of cis-3-Substituted-2-vinylaziridines with Heteroatom Nucleophiles
Bouillon et al. Efficient synthesis of esters containing tertiary amine functionalities via active cyanomethyl ester intermediates
Leiris et al. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework
CA3032963C (en) Synthesis of (s)-2-amino-4-methyl-1-((r)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
Jacobo et al. An efficient preparation of stereospecific β-hydroxy nitriles
CN104031060B (zh) 青蒿素简化类似物及其制备方法和用途
JP6426015B2 (ja) 光学活性含フッ素アミン化合物及びその製造方法
ITMI20040582A1 (it) Processo per la semisintesi di deserpidina
JP5645537B2 (ja) ヒドロキシエステル誘導体の製造方法

Legal Events

Date Code Title Description
FG Grant, registration